Plain-English translation of NCT06988956 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether , a new medication, works better when combined with standard radiation and chemotherapy treatment for advanced esophageal cancer in patients aged 70 and older. About half of participants will receive along with radiation and chemotherapy, while the other half will receive radiation and chemotherapy alone. The trial will compare how well each treatment works and how safe it is.
Advanced esophageal cancer in older patients is difficult to treat, and current standard treatments don't work well enough for many people. Researchers believe that this medication might help the radiation and chemotherapy work better by targeting cancer cells in a different way, potentially improving survival and quality of life.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital regularly over about one year. During the first phase, you will receive radiation treatment along with chemotherapy pills taken twice daily, and the medication given by IV infusion once weekly for the first month. After radiation finishes, chemotherapy continues for about a year in cycles. You will have blood tests, imaging scans, and check-ups to monitor how well the treatment is working and watch for side effects. Your doctors will follow your health for survival tracking even after treatment ends.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China